Veterinary Medicines

Utertab 2000 mg intrauterine tablet for cattle

Authorised
  • Tetracycline hydrochloride
Download as PDF

Product identification

Medicine name:
Utertab 2000 mg intrauterine tablet for cattle
Utertab 2000 mg intra-uteriene tablet voor runderen
Active substance:
  • Tetracycline hydrochloride
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intrauterine use

Product details

Active substance and strength:
  • Tetracycline hydrochloride
    2000.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Intrauterine tablet
Withdrawal period by route of administration:
  • Intrauterine use
    • Cattle (lactating cow)
      • Milk
        96
        hour
      • Meat and offal
        10
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • (ID9) 500 Intrauterine tablet: unspecified outer container with 100 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID8) 400 Intrauterine tablet: unspecified outer container with 80 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID7) 300 Intrauterine tablet: unspecified outer container with 60 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID6) 200 Intrauterine tablet: unspecified outer container with 40 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID5) 100 Intrauterine tablet: unspecified outer container with 20 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID4) 50 Intrauterine tablet: unspecified outer container with 10 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID3) 20 Intrauterine tablet: unspecified outer container with 4 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID2) 10 Intrauterine tablet: unspecified outer container with 2 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Animedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Animedica GmbH
  • Animedica Herstellungs GmbH
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 121809
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0176/001
Concerned member states:
  • Bulgaria
  • Croatia
  • Hungary
  • Ireland
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 8/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."